About

Mr. Harrison has served as a director of Acurx since July 2021. Since June 2016 he has been Chairman Emeritus of the Diversified Agency Services (DAS) division of Omnicom Group Inc. (NYSE: OMC), having previously served as its President and then Chairman and Chief Executive Officer; under his leadership DAS grew into Omnicom's largest division with annual revenues over $6.0 billion. He joined Omnicom in 1992 when it acquired Harrison & Star Business Group, the healthcare agency he co-founded, and in 2019 became a Senior Operating Partner at Merida Capital Partners. Mr. Harrison began his career at Pfizer Laboratories as a pharmaceutical sales representative. He earned an L.H.D. and M.S. in cell biology from West Virginia University and a B.S. in cell biology and physiology from Shepherdstown University.

Roles

Acurx Pharmaceuticals, Inc.
Director · Current role
July 2021–present
Omnicom Group Inc. - Diversified Agency Services (DAS)
Chairman Emeritus
2016 - present
Omnicom Group Inc. - Diversified Agency Services (DAS)
Chairman & Chief Executive Officer
1998 - 2013
Merida Capital Partners
Senior Operating Partner
2019 - present
Harrison & Star Business Group
Co-Founder & Chairman

External Roles

Madison Logic
Director
2017 - present
New Frontier Data
Director
2022 - present
ACTV8me
Director
2019 - present
MainStem
Director
Zynerba Pharmaceuticals
Director
2015 - 2019
Dipexium Pharmaceuticals, Inc.
Director
2011 - 2017

Director Compensation

FY 2024
Fees earned or paid in cash
$52,500
ComponentAnnual cash retainers and committee/leadership fees earned in 2024
Option awards
$22,104
ComponentStock options granted during 2024, ASC 718 grant-date fair value
Total
$74,604

Also at Acurx Pharmaceuticals, Inc.

Related

See how VectorShift works for your firm

Request Demo